Author

K. L. Schwertfeger

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Approach:biophysical modeling· 1 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

A. C. Nelson· 1 shared A. S. Jolicoeur· 1 shared B. F. Brian· 1 shared C. Daughters· 1 shared C. Forester· 1 shared C. Hallstrom· 1 shared C. Henzler· 1 shared C. R. Guerrero· 1 shared

Activity by Year

2019-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. C. Nelson

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Receptor for Hyaluronan-Mediated Motility (RHAMM) defines an invasive niche associated with tumor progression and predicts poor outcomes in breast cancer patients.

S. E. Tarullo, Y. He, C. Daughters, T. P. Knutson, C. Henzler, M. Price, R. Shanley, P. Witschen, C. Tolg, R. E. Kaspar, C. Hallstrom, L. Gittsovich, M. L. Sulciner, X. Zhang, C. Forester, , A. C. Nelson

This study identifies RHAMM as a marker of invasive niches in breast cancer, showing its association with poor outcomes and promoting invasion through a 27-gene signature.

bioRxiv · Jun 13, 2022Cancer Biology

Unique-region phosphorylation targets LynA for rapid degradation, tuning its expression and signaling in myeloid cells

B. F. Brian, A. S. Jolicoeur, C. R. Guerrero, M. G. Nunez, Z. E. Sychev, S. A. Hegre, P. Satrom, N. Habib, J. M. Drake, K. L. Schwertfeger, T. S. Freedman

The paper identifies how LynA is selectively degraded in macrophages via c-Cbl targeting tyrosine 32, while mast cells, with low c-Cbl, maintain high LynA levels, affecting signaling.

bioRxiv · Jul 2, 2019Biochemistry